Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hungary's Egis appoints new CFO

This article was originally published in Scrip

Executive Summary

Hungary's second-largest manufacturer of generic pharmaceuticals, Egis, has appointed Csaba Poroszlai as its new chief financial officer, effective from the end of this month. He will replace Dr Laszlo Marosffy, who is set to retire. Mr Poroszlai was most recently head of strategic controlling at Egis. He was also CFO of Beres Pharmaceuticals, another local company, from 2003-08 before he joined Egis.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC011366

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel